Welcome to our dedicated page for Ascend Wellness news (Ticker: AAWH), a resource for investors and traders seeking the latest updates and insights on Ascend Wellness stock.
Ascend Wellness Holdings, Inc. (AWH) (CSE: AAWH.U, OTCQX: AAWH) is a vertically integrated, multi-state cannabis operator whose news flow centers on retail expansion, branded product launches, and financial performance. As a cannabis company with assets in Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania, AWH regularly issues updates that reflect developments across its cultivation, manufacturing, and retail operations.
News about AWH often highlights the opening of new dispensaries and partner locations. Recent examples include the launch of a new dispensary in Englewood, Ohio, which serves both medical patients and non-medical customers, and the approval and build-out of a partner store in Little Falls, New Jersey under Assembly Bill A4151. These announcements typically describe how new stores fit into the company’s densification strategy and expand its retail footprint in regulated markets.
Investors and industry followers will also see recurring coverage of AWH’s quarterly financial results, reported under U.S. GAAP and supplemented by non-GAAP metrics such as Adjusted EBITDA, Adjusted Gross Profit, Net Debt, and Free Cash Flow. Earnings releases discuss revenue trends across retail and wholesale channels, margin performance, cost-saving initiatives, and capital structure actions such as refinancings, mortgage loans, and senior secured note offerings.
Another key theme in AWH news is brand and product innovation. The company provides updates on the rollout of in-house brands like High Wired, Effin', Ozone, Ozone Reserve, Simply Herb, Common Goods, Honor Roll, and Royale, along with new SKUs across vapes, infused flower, pre-rolls, and gummies. AWH also issues announcements about its digital initiatives, including the launch of a fully refreshed e-commerce ecosystem, the Ascend Dispensary App, Ascend Pay, and the Ascenders Club loyalty program.
For readers tracking AAWH news, this page aggregates press releases on store openings, partnerships, financial results, capital markets transactions, technology upgrades, and social equity initiatives, offering a consolidated view of the company’s operational and strategic updates over time.
Ascend Wellness Holdings (AAWH) has announced a new share buyback program starting January 2, 2025. The company received authorization to repurchase up to 10,215,690 shares (approximately 5% of outstanding common shares) or US$2.25 million worth of common shares, whichever is lesser. The buyback program will run through January 1, 2026, with purchases to be made on the CSE, OTCQX, or alternative trading systems through ATB Securities Inc.
As of December 24, 2024, AAWH had 204,313,808 outstanding common shares. CEO Sam Brill emphasized that this initiative, along with recent board member purchases, demonstrates confidence in the company's strategy and commitment to shareholder value. All purchased shares will be cancelled, and the program can be modified or terminated at any time.
Ascend Wellness Holdings (AAWH) has completed the repurchase and cancellation of 11,000,000 shares of its Class A common stock, representing over 5% of outstanding shares, from an institutional investor at a significant discount to the CSE closing price on December 17, 2024. The company received consent from term loan holders to repurchase up to $5 million of shares.
The transaction, unanimously approved by AWH's Board of Directors, aims to reduce stock pressure and float. CEO Sam Brill emphasized that current market valuation doesn't reflect the company's true value and strength. The company focuses on improving margins, densifying retail footprint, and generating sustainable cash flow as it enters 2025.
Ascend Wellness Holdings (CSE: AAWH.U, OTCQX: AAWH) reported its Q3 2024 financial results. Net revenue reached $141.6 million, a 0.3% year-over-year and 0.1% quarter-over-quarter increase. Retail revenue was $93.6 million, a 7.6% year-over-year decrease but a 0.6% quarter-over-quarter increase. Wholesale revenue increased 20.1% year-over-year but decreased 0.8% quarter-over-quarter to $48.0 million. The net loss was $28.3 million, compared to $11.2 million in Q3 2023 and $21.8 million in Q2 2024. Adjusted EBITDA was $25.1 million, a 14.9% year-over-year and 11.4% quarter-over-quarter decline. The company aims to save $30 million annually through transformation initiatives and has reduced management headcount by 15% and retail and operations headcount by 10%. Cash and cash equivalents stood at $65.3 million with a net debt of $240.6 million. AWH also launched a new edibles brand, Effin', which quickly became a top seller.
Ascend Wellness Holdings (AWH) has launched Effin', a new edibles-only brand focusing on targeted cannabis experiences. The brand combines THC with minor cannabinoids like THCV, CBN, CBG, and CBD to deliver specific effects. The initial product line includes four SKUs:
1. Effin' Chillin': 10 mg THC to 10 mg CBD for relaxation
2. Effin' Sleep: 10 mg THC to 5 mg CBN for better sleep
3. Effin' Hang: 20 mg CBG to 10 mg THC for balanced energy
4. Effin' Do It: 10 mg THC to 10 mg THCV for motivation and focus
Effin' launched in Massachusetts and Illinois in early October, with a New Jersey launch planned for late October 2024. The brand aims to provide consistent, reliable effects tailored to customers' needs.
Ascend Wellness Holdings (AWH), a leading multi-state, vertically integrated cannabis operator, has announced its upcoming third quarter 2024 earnings conference call. The call is scheduled for Tuesday, November 12, 2024, at 8:30 AM ET, following the release of the company's financial results. Investors can access the call by dialing 1 (888) 699-1199 or through a live webcast available on the AWH investor relations website.
AWH operates in Illinois, Maryland, Massachusetts, Michigan, Ohio, New Jersey, and Pennsylvania, with state-of-the-art cultivation facilities producing award-winning strains and a curated product selection. The company distributes its in-house brands including Common Goods, Simply Herb, Ozone, Ozone Reserve, and Royale.
Ascend Wellness Holdings (CSE: AAWH-U.CN, OTCQX: AAWH) has opened its fifth medical dispensary in Pennsylvania, located in Whitehall. This marks the company's 39th location across seven states. The new Ascend Dispensary Outlet Whitehall will serve patients in the greater Allentown area, offering a wide range of medical marijuana products.
The grand opening is scheduled for September 13th, featuring a ribbon-cutting ceremony and local vendor pop-ups. Ascend's outlet dispensary model focuses on high-quality products at consistently low prices, with expertly trained staff. The company also offers a rewards program called the Ascenders Club, where patients can earn points on purchases.
Ascend Wellness Holdings (AAWH) has announced significant leadership changes as part of its strategy to align operations with long-term goals and financial priorities. Samuel Brill, current Director, has been appointed as CEO, replacing John Hartmann. Francis Perullo, Co-Founder and current director, has been named President, while Roman Nemchenko, previously Chief Accounting Officer, has been promoted to CFO.
These changes aim to enhance operational efficiency and financial performance. The new leadership team is focused on improving margins, cash flow, and driving sustainable growth. The company's Executive Chair, Abner Kurtin, expressed confidence that these changes will bring focus back to fundamentals and position AWH for future success.
Ascend Wellness Holdings (CSE: AAWH-U.CN, OTCQX: AAWH) has expanded non-medical cannabis sales to its fifth Ohio location in Carroll. This follows the successful launch at four other dispensaries last week, which saw daily sales triple from $12,740 to $33,864. CEO John Hartmann reported revenue surges of at least 3x at the first four stores.
Ohio's cannabis market showed $484.4 million in medical sales in 2023, demonstrating significant potential. Ascend operates five dispensaries and a cultivation facility in Ohio, producing branded products including vapes, gummies, and flower. The company is well-positioned to meet growing demand in this evolving market.
Ascend Wellness Holdings (CSE: AAWH-U.CN, OTCQX: AAWH) has expanded access to non-medical cannabis customers in Ohio. Starting August 6th, the company can sell to customers over 21 at its dispensaries in Coshocton, Cincinnati, and Sandusky, with Piqua following on August 7th. Ascend operates five dispensaries in Ohio and a cultivation and manufacturing facility, producing Common Goods, Simply Herb, and Ozone branded products.
CEO John Hartmann emphasized Ascend's commitment to serving both medical patients and new non-medical customers while maintaining high standards of safety, compliance, and quality. Ohio's cannabis market reported $484.4 million in medical cannabis sales in 2023, demonstrating significant potential for growth as the state transitions to allow dual-use dispensaries.
Ascend Wellness Holdings (AAWH) reported its Q2 2024 financial results, showing 15.1% year-over-year growth in net revenue to $141.5 million. The company achieved a 32.9% increase in Adjusted EBITDA to $28.3 million, representing a 20.0% margin. AWH generated positive cash flow from operations for the sixth consecutive quarter, with approximately $32 million in Q2. However, the company faced challenges, including retail headwinds in some markets. As a result, AWH revised its full-year guidance, now anticipating net revenue growth between 11-13% and Adjusted EBITDA growth between 5-10% for 2024 compared to the previous year. The company also successfully refinanced $215 million of its existing term loan and opened new dispensaries in Pennsylvania and New Jersey.